共 6 条
[1]
[2]
[3]
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction[J] Damien Gruson;Thibault Lepoutre;Sylvie A. Ahn;Michel F. Rousseau International Journal of Cardiology 2014,
[4]
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure[J] Shafiq U. Rehman;Thomas Mueller;James L. Januzzi Journal of the American College of Cardiology 2008,
[5]
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)[J] Sharon Ann Hunt;William T. Abraham;Marshall H. Chin;Arthur M. Feldman;Gary S. Francis;Theodore G. Ganiats;Mariell Jessup;Marvin A. Konstam;Donna M. Mancini;Keith Michl;John A. Oates;Pete
[6]
Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker[J] Ellen O. Weinberg;Masahisa Shimpo;Shelley Hurwitz;Shin-ichi Tominaga;Jean-Lucien Rouleau;Richard T. Lee Circulation: Journal of the American Heart Association 2003,

